Dr. Kumar on Defining Multiple Myeloma

Video

In Partnership With:

Shaji Kumar, MD, professor of Medicine, Mayo Clinic, gives an overview on the expanded definition of multiple myeloma.

Shaji Kumar, MD, professor of Medicine, Mayo Clinic, gives an overview on the expanded definition of multiple myeloma.

Multiple myeloma that requires treatment, Kumar explains, is when organ damage such as high calcium, bone disease, anemia, and/or kidney issues occur. However, the definition of multiple myeloma has been expanded to include biomarkers that predict for development of these characteristics. It has also been expanded to include patients who have more than 60% of plasma cells in their bone marrow, have a free light chain ratio of more than 100, or have one or more lesions found on MRI or PET scans.

Researchers have determined that among patients who harbor one of these characteristics, the risk of having symptomatic or active multiple myeloma in 2 years is over 80%. Thus, it may be more beneficial to treat these patients earlier, Kumar says.

Related Videos
Jeremy M. Pantin, MD, clinical director, Adult Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, bone marrow transplant physician, Sarah Cannon Research Institute
Maria Hafez, MD, assistant professor, breast and sarcoma medical oncologist, director, Clinical Breast Cancer Research, Sidney Kimmel Medical College, Thomas Jefferson University
Zeynep Eroglu, MD
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Akriti Jain, MD
Raj Singh, MD
Gottfried Konecny, MD
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Ramez N. Eskander, MD